Friday, November 17, 2023

Friday, November 17, 2023

Wednesday, November 15, 2023

Wednesday, November 15, 2023

Wednesday, November 15, 2023

Wednesday, November 15, 2023

Ventilacijske cjevčice (umetci) kod djece s upalom srednjeg uha s izljevom Ključne poruke - Na temelju istraživanja uključenih u ovaj sustavni pregled, autori nisu sigurni u kojoj mjeri ventilacijske cjevčice poboljšavaju sluh. „Ljepljivo uho” promjenjivo je stanje s visokim stopama spontanog oporavka i povratka, što otežava proučavanje u kliničkom istraživanju. - Ventilacijske cjevčice mogu blago smanjiti broj djece koja imaju „ljepljivo uho” tri do šest mjeseci praćenja nakon liječenja. Nije poznato imaju li one učinak i tijekom dužih vremenskih razdoblja. - Prema istraživanjima...

Različiti antibiotici za liječenje upale grla uzrokovane streptokokom skupine A Koji je antibiotik bolji za faringitis (upalu grla)? Ključne poruke Učinak na povlačenje simptoma grlobolje/faringitisa uzrokovanog beta-hemolitičkim streptokokom skupine A (BHS-A) bio je sličan kod različitih antibiotika. Svi antibiotici mogu uzrokovati nuspojave. Što je faringitis? Faringitis (ili upala grla) je upala koju uzrokuju virusi ili bakterije (npr. beta-hemolitički streptokok skupine A). Obično prođe bez liječenja. Rizik od komplikacija iznimno je nizak za većinu ljudi u zemljama s visokim dohotkom....

Tuesday, November 14, 2023

Koje su dobrobiti i rizici programa zdravstvenog opismenjavanja za migrante? Zdravstvena pismenost označava znanje, motivaciju i kompetencije (npr. sposobnosti čitanja i pisanja) koje su ljudima potrebne za pronalaženje, razumijevanje, procjenu i korištenje zdravstvenih informacija. Migranti su izloženi riziku od poteškoća sa zdravstvenom pismenosti (npr. kada ne poznaju dobro zdravstveni sustav države). „Generička” zdravstvena pismenost omogućava ljudima pronalaženje, razumijevanje i korištenje općih zdravstvenih informacija kako bi donosili zdravstvene odluke. Zdravstvena pismenost „o...

Monday, November 13, 2023

Brusnice za sprječavanje infekcija mokraćnog sustava Što je proučavano u ovom sustavnom pregledu? Brusnice (sok od brusnice, tablete ili kapsule) se već godinama koriste za prevenciju infekcija mokraćnog sustava (IMS). Brusnice sadrže proantocijanidine (PAC), tvari koje mogu spriječiti prianjanje bakterija na stijenke mjehura. To može pomoći u sprječavanju infekcija i smanjiti vrijeme provedeno kod liječnika. Međutim, trenutno ne postoji utvrđeni režim doziranja PAC niti formalna regulacija proizvoda od brusnice. Konkretno, postoji mogućnost da preporučene doze ne budu navedene na pakiranju....

Liječenje buloznog pemfigoida Koji su pristupi najučinkovitiji u liječenju buloznog pemfigoida (rijetka bolest kože koja uzrokuje mjehuriće, svrbež i suhu kožu)? Ključne poruke • Krema koja sadrži lokalni steroid klobetazol propionat, primijenjena na cijeloj površini kože, jednako je učinkovita kao oralna terapija steroidima (prednizon), uzrokuje manje ozbiljnih neželjenih ili štetnih učinaka i može smanjiti smrtnost. • Početno liječenje doksiciklinom (200 mg dnevno), antibiotikom protuupalnog djelovanja, dovodi do prihvatljive kontrole mjehura kože u kratkoročnom razdoblju u usporedbi s...

Nebulizatori za primjenu lijekova za cističnu fibrozu Ključne poruke 1. Novije tehnologije imaju prednosti u odnosu na konvencionalne sustave u smislu trajanja liječenja, količine lijeka koja dolazi do pluća, preferencija pacijenata i pridržavanja uzimanju terapije. 2. Ne mogu se svi lijekovi koji se koriste u liječenju cistične fibroze primijeniti istim nebulizatorom, a nedostaju podatci za neke od različitih kombinacija nebulizatora i lijekova. 3. Potrebna su dugoročna istraživanja za procjenu različitih sustava nebulizatora kako bi se odredili ishodi usmjereni na pacijenta (kao što je...

Tuesday, November 7, 2023

Koristi i rizici operativnog i neoperativnog liječenja slomljene petne kosti Ključne poruke • Kod osoba koje su slomile petnu kost, operacija može poboljšati funkcionalnost stopala i gležnja do dvije godine nakon ozljede u usporedbi s neoperativnim liječenjem. • Operacija također može smanjiti broj ljudi koji pate od bolova do dvije godine nakon ozljede te može neznatno poboljšati njihovu kvalitetu života. • Dokazi su proizašli samo iz nekoliko manjih istraživanja koja nisu uvijek bila dobro provedena, što znači da dokazi nisu u potpunosti pouzdani. • Potrebno je više dobro provedenih...

Cochrane's members and supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.

Getting involved in Cochrane’s work means becoming part of a global community. The Cochrane International Mobility programme connects successful applicants with a placement in a host Cochrane Group, where they learn about the production, use, and knowledge translation of Cochrane reviews. The prgramme offers opportunities for learning and training not only for participants but also for host staff.

In this series, we profile those who have participated in the Cochrane International Mobility Program and learn more about their experiences.

Name: Milena
Location: Germany
CIM Location: Cochrane Sweden

How did you first learn about Cochrane? 
I first learned about Cochrane in my Bachelor studies back in Munich. In some of our research modules several lecturers mentioned systematic reviews by Cochrane having the highest level of evidence and being internationally renowned in research. In my Master studies it was mandatory to complete an internship and I wanted to take the opportunity to go abroad. Back in Germany, I worked in a research team at the 'Haunersche children's hospital'. My boss, who has completed a Cochrane course before, contacted Martin who forwarded contact to Matteo and introduced me to Cochrane Sweden and its department for Neonatology. 

What was your experience with your Cochrane International Mobility? 
Since my Bachelor studies, I've always been interested in the field of research and worked in several jobs regarding the health of children and adolescents. Conducting a systematic review in the field of Neonatology was one thing I was still missing. Cochrane has proved to be an outstanding place of internship: the content is high-quality, the communication runs smoothly and the supervision is excellent. I really liked working in such an international team.

What are you doing now in relation to your Cochrane International Mobility experience? 
Right now, we have just finished a Cochrane review about strategies for cessation of caffeine administration in preterm infants. Additionally, I am collaborating with other amazing teams in a review protocol regarding infant positioning as well as a methods paper about imputing risk ratio from rate data. Also, I am planning to remain a part of Cochrane. Back home, I will continue to support Matteo's team and several Cochrane projects. Cochrane's mobile way of working is just super flexible and works perfect for students from all over the world.

Do you have any words of advice to anyone considering a Cochrane International Mobility experience? 
If you're interested in research and how to perform a high-standard systematic review in practice, Cochrane is the perfect place for you. The intense exchange with international researchers, doctors, nurses, statisticians and students allows you to grow, personally as well as professionally. It will improve your English skills, your communication skills, and your knowledge about methodology in research a lot. I can deeply recommend working together with Cochrane!

Monday, November 6, 2023

Specifications: Permanent – Full Time
Salary:  £32,000 per Annum
Location: (Remote – Flexible) Candidates anywhere from the world will be considered; however, Cochrane’s Central Executive Team is only able to offer consultancy contracts outside these countries.
Closing date:  12 November 2023

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into four directorates: Evidence Production and Methods, Publishing and Technology, Development, and Finance and Corporate Services.

The Executive Assistant role will provide an efficient and responsive administrative, organisational, and logistical service to the Editor in Chief (EiC) and the leadership team of the Evidence Production & Methods Directorate (EPM). As well as support the operational activities of the directorate, including management of the Editorial Board.
      
Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values: Collaboration: Underpins everything we do, locally and globally. Relevant: The right evidence at the right time in the right format. Integrity: Independent and transparent. Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

• An opportunity to truly impact health globally
• A flexible work environment
• A comprehensive onboarding experiences
• An environment where people feel welcome, heard, and included, regardless of their differences

Cochrane welcomes applications from a wide range of perspectives, experiences, locations and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

• For further information on the role and how to apply, please click here.
• The deadline to receive your application is 12 November 2023.
• The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.
• Read our Recruitment Privacy Statement

Monday, November 6, 2023 Category: Jobs

Temperatura i uvjeti skladištenja humanog inzulina Što je inzulin? Inzulin je hormon koji proizvodi gušterača, a pomaže vašem tijelu pretvoriti hranu u energiju te kontrolira razinu šećera u krvi. Dijabetičari ne mogu proizvesti dovoljno inzulina ili ga učinkovito iskoristiti, pa ga neki moraju sami ubrizgavati. Kako treba skladištiti inzulin? Zdravstvena tijela i proizvođači lijekova preporučuju držati inzulin podalje od sunčeve svjetlosti, ne zamrzavati ga i čuvati ga u hladnjaku. Neotvorene bočice ili spremnici humanog inzulina te ulošci za inzulinske olovke trebaju se čuvati na...

Koje su dobrobiti i štete lijekova za povećanje protoka krvi (inhibitora fosfodiesteraze tipa 5 (PDE5i)) u usporedbi s placebom za liječenje Raynaudovog fenomena? Ključne poruke PDE5 inhibitori mogu neznatno smanjiti učestalost i trajanje napadaja Raynaudovog fenomena i mogu poboljšati pacijentovu opću procjenu bolesti, ali vjerojatno malo ili nimalo ne utječu na bol u usporedbi s placebom. Nije jasno imaju li PDE5 inhibitori učinka na jačinu napadaja bolesti. U usporedbi s ljudima liječenim placebom, za osobe liječene inhibitorima PDE5 vjerojatnije je da će ranije završiti s liječenjem, ali...